“Experimental and computational evidence for xanthatin as a multi-target anti-cancer agent in ovarian cancer”, Bangladesh J Pharmacol, vol. 20, no. 4, pp. 158–168, Oct. 2025, doi: 10.3329/bjp.v20i4.84621.